18,400 resources
By Version
By Authority
Start Prev Rows 7800 - 8000 Next
| Package | Version | Identity | Name/Title | Status | FMM | WG | Date | Auth |
|---|---|---|---|---|---|---|---|---|
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2166 | Hantavirus Infection (Test Panels for Hantavirus IgM IgG Total Antibody) | active | 2025-02 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2167 | Organisms (Tests in Cerebrospinal Fluid by Culture and Identification Method) | active | 2023-06 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2168 | Viruses [Causing Encephalitis] (Tests for Viruses Causing Encephalitis in Unspecified Specimen by Culture and Identification) | active | 2024-06 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2169 | Viruses [Causing Encephalitis] (Tests for Viruses Causing Encephalitis in Cerebrospinal Fluid by Culture and Identification) | active | 2023-06 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2170 | Bacteria [Causing Encephalitis] (Tests for Bacteria Causing Encephalitis in Unspecified Specimen by Culture and Identification) | active | 2024-06 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2171 | Fungi [Causing Encephalitis] (Tests for Fungi Causing Encephalitis in Unspecified Specimen by Culture and Identification) | active | 2023-06 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2172 | Viruses [Causing Encephalitis] (Tests for Viruses Causing Encephalitis Nucleic Acid in Unspecified Specimen) | active | 2024-06 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2173 | Bacteria [Causing Encephalitis] (Tests for Bacteria Causing Encephalitis Nucleic Acid in Unspecified Specimen) | active | 2024-06 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2174 | Fungi [Causing Encephalitis] (Tests for Fungi Causing Encephalitis Nucleic Acid in Unspecified Specimen) | active | 2024-06 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2175 | Parasites [Causing Encephalitis] (Tests for Parasites Causing Encephalitis Nucleic Acid in Unspecified Specimen) | active | 2024-06 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2176 | Viruses [Causing Encephalitis] (Tests for Viruses Causing Encephalitis Antigen in Unspecified Specimen) | active | 2024-06 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2177 | Fungi [Causing Encephalitis] (Tests for Fungi Causing Encephalitis Antigen in Unspecified Specimen) | active | 2024-06 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2178 | Bacteria [Causing Encephalitis] (Tests for Bacteria Causing Encephalitis Antigen in Unspecified Specimen) | active | 2024-06 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2179 | Parasites [Causing Encephalitis] (Tests for Parasites Causing Encephalitis Antigen in Unspecified Specimen) | active | 2023-06 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.218 | Listeriosis (Disorders) (ICD10CM) | active | 2024-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2180 | Parasites [Causing Encephalitis] (Tests for Parasites Causing Encephalitis in Unspecified Specimen by Microscopic Observation) | active | 2024-06 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2181 | Organisms (Tests by Microscopic Observation in Cerebrospinal Fluid) | active | 2023-06 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2183 | Bacteria [Causing Encephalitis] (Tests for Bacteria Causing Encephalitis Nucleic Acid in Cerebrospinal Fluid) | active | 2024-06 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2187 | Fungi [Causing Encephalitis] (Tests for Fungi Causing Encephalitis Nucleic Acid in Cerebrospinal Fluid) | active | 2023-06 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2188 | Fungi [Causing Encephalitis] (Tests for Fungi Causing Encephalitis Antigen in Cerebrospinal Fluid) | active | 2024-06 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2189 | Parasites [Causing Encephalitis] (Tests for Parasites Causing Encephalitis in Cerebrospinal Fluid by Microscopic Observation) | active | 2023-06 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2190 | Parasites [Causing Encephalitis] (Tests for Parasites Causing Encephalitis Nucleic Acid in Cerebrospinal Fluid) | active | 2024-06 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2192 | Viruses [Causing Encephalitis] (Tests for Viruses Causing Encephalitis Nucleic Acid in Cerebrospinal Fluid) | active | 2024-06 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2193 | Viruses [Causing Encephalitis] (Tests for Viruses Causing Encephalitis Antigen in Cerebrospinal Fluid) | active | 2023-06 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2196 | Lung Tissue (Specimen Type) (SNOMED) | active | 2024-06 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2197 | Granuloma [Unspecified] (Finding by Microscopic Observation in Lab Results) | active | 2023-06 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2198 | Anaplasmosis (Disorders) (ICD10CM) | active | 2023-06 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2199 | NU_Organisms (Tests in Specimen from Wound by Culture and Identification Method | active | 2023-06 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2200 | Organisms (Tests by Animal Inoculation Method) | active | 2023-06 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2201 | Agricultural Chemical Poisoning [Unspecified Chemical] (Disorders) (ICD10CM) | active | 2023-06 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2202 | Abnormal Lung Sounds (SNOMED) | active | 2023-06 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2203 | Abnormal Lung Sounds (ICD10CM) | active | 2023-06 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2204 | Anemia [Unspecified Cause] (SNOMED) | active | 2023-06 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2205 | Anemia [Unspecified Cause] (ICD10CM) | active | 2023-06 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2206 | Creatinine (Tests in Serum by Any Method) | active | 2024-06 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2207 | Microangiopathic Changes (Schistocytes, Burr cells, or Helmet cells) (Tests by Microscopic Observation in Unspecified Specimen) | active | 2023-06 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2208 | Microangiopathic Changes (Schistocytes, Burr cells, or Helmet cells) (Tests by Microscopic Observation in Blood) | active | 2023-06 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2209 | Microangiopathic Changes (Schistocytes, Burr cells, or Helmet cells) (Organism or Substance in Lab Results) | active | 2023-06 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2210 | Histopathology or Cytopathology Tests by Microscopic Observation | active | 2023-06 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2211 | Ehrlichiosis (Tests for Ehrlichia species IgG Antibody) | active | 2024-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2212 | Invasive Cronobacter Infection (Organism or Substance in Lab Results) | active | 2024-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2213 | Invasive Cronobacter Infection (Tests for Cronobacter species by Culture and Identification Method) | active | 2024-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2214 | Necrotizing Enterocolitis (SNOMED) | active | 2024-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2215 | Necrotizing Enterocolitis (ICD10CM) | active | 2024-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2216 | Abscess [Brain] (SNOMED) | active | 2024-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2217 | Abscess [Brain] (ICD10CM) | active | 2024-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2218 | Urinary Tract Infection (SNOMED) | active | 2025-02 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2219 | Urinary Tract Infection (ICD10CM) | active | 2024-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2220 | Amniotic Fluid (Specimen Type) (SNOMED) | active | 2024-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2221 | Congenital Cytomegalovirus (Organism or Substance in Lab Results) | active | 2024-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2222 | Organisms (Tests in Amniotic Fluid by Culture and Identification Method) | active | 2024-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2223 | Congenital Cytomegalovirus (Tests for CMV Antigen by Immunohistochemical Stain) | active | 2024-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2224 | Congenital Cytomegalovirus (Tests for CMV Antigen in Tissue by Immunohistochemical Stain) | active | 2024-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2225 | Congenital Cytomegalovirus (Tests for CMV in Amniotic Fluid by Culture and Identification Method) | active | 2024-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2226 | Congenital Cytomegalovirus (Tests for CMV Nucleic Acid in Amniotic Fluid by NAAT) | active | 2024-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2227 | Congenital Cytomegalovirus (Tests for CMV Antigen in Whole Blood) | active | 2024-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2228 | Congenital Cytomegalovirus (Tests for CMV Antigen) | active | 2024-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2229 | Congenital Cytomegalovirus (Tests for CMV by Culture and Identification Method) | active | 2024-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2230 | Congenital Cytomegalovirus (Tests for CMV Nucleic Acid by NAAT) | active | 2025-02 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2231 | Congenital Cytomegalovirus Infection (Disorders) (SNOMED) | active | 2024-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2232 | Congenital Cytomegalovirus Infection (Disorders) (ICD10CM) | active | 2024-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2233 | Cytomegalovirus Disease (Disorders) (SNOMED) | active | 2025-02 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2234 | Cytomegalovirus Disease (Disorders) (ICD10CM) | active | 2024-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2235 | Toxoplasmosis (Tests for Toxoplasma gondii Antigen by Immunohistochemical Stain) | active | 2024-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2236 | Toxoplasmosis (Tests for Toxoplasma gondii Antigen in Tissue by Immunohistochemical Stain) | active | 2024-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2237 | Toxoplasmosis (Tests for Toxoplasma gondii IgG IgM IgA or IgE Antibody) | active | 2024-06 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2238 | Toxoplasmosis (Tests for Toxoplasma gondii IgG IgM IgA or IgE Antibody in Blood) | active | 2024-06 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2239 | Toxoplasmosis (Tests for Toxoplasma gondii IgG or IgM Antibody) | active | 2024-06 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2240 | Toxoplasmosis (Tests for Toxoplasma gondii IgG or IgM Antibody in Cerebrospinal Fluid) | active | 2024-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2241 | Stillbirth (SNOMED) | active | 2024-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2242 | Stillbirth (ICD10CM) | active | 2024-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2243 | Zika Virus Disease (Tests for Zika virus IgM Antibody in Blood or CSF) | active | 2024-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2244 | Candida species (Tests by Culture and Identification Method) | active | 2025-02 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2245 | Organisms (Tests in Extrapulmonary Specimen by Culture and Identification) | active | 2025-02 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2246 | Organisms (Tests for Nucleic Acid in Extrapulmonary Specimen) | active | 2024-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2247 | Extrapulmonary [NTM] (Specimen Type) (SNOMED) | active | 2025-02 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2248 | Plasmodium species (Tests by Microscopic Observation) | active | 2024-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2249 | Baylisascariasis (Tests for Baylisascaris species Antibody in Serum or CSF) | active | 2024-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2250 | Lower Respiratory [Excluding Sputum] (Specimen Type) (SNOMED) | active | 2024-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2251 | Organisms (Tests in Sputum Specimen by Culture and Identification Method) | active | 2024-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2252 | Organisms (Tests in Lower Respiratory Specimen [Excluding Sputum] by Culture and Identification Method) | active | 2025-02 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2253 | Organisms (Tests for Nucleic Acid in Lower Respiratory Specimen [Including Sputum] ) | active | 2024-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2254 | Nontuberculous Mycobacteria Infection, Pulmonary (Tests for Mycobacterium species in Lower Respiratory Specimen [Excluding Sputum] by Culture and Identification Method) | active | 2024-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2255 | Carbapenem Resistant Bacterial Infection [Carbapenemase Producing] (SNOMED) | active | 2024-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2256 | CP_CRE (Disorders) (SNOMED) | active | 2024-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2257 | Organisms (Tests in Stool by Culture and Identification Method) | active | 2024-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2258 | Loss of Consciousness (ICD10CM) | active | 2024-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2259 | Neonatal Abstinence Syndrome (Disorders) (SNOMED) | active | 2024-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2260 | Neonatal Abstinence Syndrome (Disorders) (ICD10CM) | active | 2024-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2261 | High Pitched Cry (SNOMED) | active | 2024-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2262 | Inability to Console (SNOMED) | active | 2024-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2263 | Inability to Console (ICD10CM) | active | 2024-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2264 | Hypertonia (SNOMED) | active | 2024-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2265 | Hypertonia (ICD10CM) | active | 2024-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2266 | Tremors (SNOMED) | active | 2025-02 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2267 | Tremors (ICD10CM) | active | 2024-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2268 | Myoclonus (SNOMED) | active | 2024-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2269 | Myoclonus (ICD10CM) | active | 2024-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2270 | Poor Sleep (SNOMED) | active | 2025-02 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2271 | Poor Sleep (ICD10CM) | active | 2024-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2272 | Alterations in Feeding (SNOMED) | active | 2025-02 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2273 | Alterations in Feeding (ICD10CM) | active | 2024-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2274 | Excoriation (SNOMED) | active | 2024-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2275 | Excoriation (ICD10CM) | active | 2024-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2276 | Sneezing (SNOMED) | active | 2025-02 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2277 | Sneezing (ICD10CM) | active | 2024-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2278 | Nasal Congestion (SNOMED) | active | 2024-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2279 | Nasal Congestion (ICD10CM) | active | 2024-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2280 | Yawning (SNOMED) | active | 2024-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2281 | Cutaneous Mottling (SNOMED) | active | 2024-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2282 | Sweating (SNOMED) | active | 2025-02 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2283 | Sweating (ICD10CM) | active | 2024-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2284 | Feeding Intolerance (SNOMED) | active | 2024-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2285 | Feeding Intolerance (ICD10CM) | active | 2024-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2286 | Respiratory Distress or Nasal Flaring (SNOMED) | active | 2025-02 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2287 | Respiratory Distress or Nasal Flaring (ICD10CM) | active | 2024-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2288 | In Utero Exposure to Opioids, Benzodiazepines, or Barbiturates (ICD10CM) | active | 2024-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2289 | In Utero Substance Exposure (SNOMED) | active | 2024-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2290 | In Utero Substance Exposure (ICD10CM) | active | 2024-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2291 | Childbirth (SNOMED) | active | 2024-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2292 | Childbirth (ICD10CM) | active | 2024-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2293 | Opioids, Benzodiazepines, or Barbiturates (Tests by Any Method) | active | 2025-02 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2294 | NonOpioid, NonBenzodiazepine, and NonBarbiturate Substances (Tests by Any Method) | active | 2025-02 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2295 | Opioids, Benzodiazepines, or Barbiturates (Organism or Substance in Lab Results) | active | 2024-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2296 | NonOpioid, NonBenzodiazepine, or NonBarbiturate Substances (Organism or Substance in Lab Results) | active | 2024-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2297 | Exposure or suspected exposure to harmful algae or algae toxins (SNOMED) | active | 2024-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2298 | Exposure or suspected exposure to harmful algae or algae toxins (ICD10CM) | active | 2024-01 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2299 | Group A Streptococcus (Tests for Group A Strep in Specimen from Normally Sterile Site by Culture and Identification Method) | active | 2025-02 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2300 | Babesia species (Tests by Microscopic Observation) | active | 2024-06 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2301 | Babesia species (Tests by Microscopic Observation in Blood by Giemsa, Wright, or Wright_Giemsa Stain) | active | 2024-06 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2302 | Babesia species (Tests by Microscopic Observation by Giemsa, Wright, or Wright_Giemsa Stain) | active | 2024-06 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2305 | Gram_negative Diplococcus (Organism or Substance in Lab Results) | active | 2024-06 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2306 | Pertussis (Test Panels for Bordetella pertussis and Bordetella parapertussis Culture and Identification Method) | active | 2024-06 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2307 | D_Transposition of the Great Arteries (Disorders) (SNOMED) | active | 2024-06 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2308 | L_Transposition of the Great Arteries (Disorders) (SNOMED) | active | 2024-06 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2309 | Transposition of the Great Arteries [Unspecified] (Disorders) (SNOMED) | active | 2024-06 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2310 | Transposition of the Great Arteries [Unspecified] (Disorders) (ICD10CM) | active | 2024-06 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2311 | Interrupted Aortic Arch (Disorders) (SNOMED) | active | 2024-06 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2312 | Interrupted Aortic Arch (Disorders) (ICD10CM) | active | 2024-06 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2313 | Coarctation of the Aorta (Disorders) (SNOMED) | active | 2024-06 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2314 | Coarctation of the Aorta (Disorders) (ICD10CM) | active | 2024-06 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2315 | Ebstein Anomaly (Disorders) (SNOMED) | active | 2024-06 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2316 | Ebstein Anomaly (Disorders) (ICD10CM) | active | 2024-06 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2317 | Pulmonary valve atresia (Disorders) (SNOMED) | active | 2024-06 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2318 | Pulmonary valve atresia (Disorders) (ICD10CM) | active | 2024-06 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2319 | Pulmonary valve stenosis (Disorders) (SNOMED) | active | 2024-06 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2320 | Pulmonary valve stenosis (Disorders) (ICD10CM) | active | 2024-06 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2321 | Fetal Pulmonary valve stenosis (Disorders) (SNOMED) | active | 2024-06 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2322 | Double Outlet Right Ventricle (Disorders) (SNOMED) | active | 2024-06 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2323 | Double Outlet Right Ventricle (Disorders) (ICD10CM) | active | 2024-06 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2324 | Hypoplastic left heart syndrome (Disorders) (SNOMED) | active | 2024-06 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2325 | Hypoplastic left heart syndrome (Disorders) (ICD10CM) | active | 2024-06 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2326 | Single Ventricle (Disorders) (SNOMED) | active | 2024-06 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2327 | Single Ventricle (Disorders) (ICD10CM) | active | 2024-06 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2328 | Tetralogy of Fallot (Disorders) (SNOMED) | active | 2024-06 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2329 | Tetralogy of Fallot (Disorders) (ICD10CM) | active | 2024-06 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2330 | Truncus Arteriosus (Disorders) (SNOMED) | active | 2024-06 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2331 | Truncus Arteriosus (Disorders) (ICD10CM) | active | 2024-06 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2332 | Atrioventricular septal defect (Disorders) (SNOMED) | active | 2024-06 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2333 | Atrioventricular septal defect (Disorders) (ICD10CM) | active | 2024-06 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2334 | Total Anomalous Pulmonary Venous Connection (Disorders) (SNOMED) | active | 2024-06 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2335 | Total Anomalous Pulmonary Venous Connection (Disorders) (ICD10CM) | active | 2024-06 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2336 | Tricuspid valve atresia (Disorders) (SNOMED) | active | 2024-06 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2337 | Tricuspid valve atresia (Disorders) (ICD10CM) | active | 2024-06 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2338 | Tricuspid valve stenosis (Disorders) (SNOMED) | active | 2024-06 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2339 | Tricuspid valve stenosis (Disorders) (ICD10CM) | active | 2024-06 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2340 | Fetal Tricuspid valve stenosis (Disorders) (SNOMED) | active | 2024-06 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2341 | Exposure to Measles (SNOMED) | active | 2024-06 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2342 | Increased Risk for Exposure to Measles (SNOMED) | active | 2024-06 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2343 | Giardiasis (Tests by Microscopic Observation) | active | 2024-06 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2344 | Diphtheria (Tests for Diphtheria Toxin Nucleic Acid) | active | 2024-06 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2345 | Lead in Blood (Tests for Lead in Venous Blood) | active | 2024-06 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2346 | Lead in Blood (Tests for Lead in Capillary Blood) | active | 2024-06 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2347 | Opioid Overdose and Poisoning (Test Panels for Opioids) | active | 2025-02 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2348 | Rubella (Test Panels for rubella virus IgM Antibody) | active | 2024-06 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2349 | Consistent with Tuberculosis (Finding in Chest Xray Imaging Results) | active | 2024-06 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2350 | Acute Viral Hepatitis (ICD10CM) | active | 2024-06 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2351 | Shigellosis (Combination Tests that include Shigella species by Culture and Identification) | active | 2024-06 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2352 | Acid Fast Bacilli (Tests by Microscopic Observation by Fite Stain) | active | 2024-06 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2353 | Acid Fast Bacilli (Tests by Microscopic Observation in Skin or Unspecified Tissue by Fite Stain) | active | 2024-06 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2354 | Organisms (Tests by Microscopic Observation by Unspecified Acid Fast Stain) | active | 2024-06 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2355 | Organisms (Tests by Microscopic Observation by Unspecified Acid Fast Stain in Skin) | active | 2024-06 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2356 | Skin (Specimen Type) (SNOMED) | active | 2024-06 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2357 | Organisms (Tests by Microscopic Observation in Skin) | active | 2024-06 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2358 | Unspecified Tissue (Specimen Type) (SNOMED) | active | 2024-06 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2360 | S. Paratyphi Infection (Tests for S. Paratyphi by Culture and Identification Method) | active | 2024-06 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2361 | S. Paratyphi Infection (Tests for S. Paratyphi Nucleic Acid) | active | 2024-06 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2368 | Perinatal Hepatitis B (Maternal Hepatitis B Virus Infection) (Disorders) (SNOMED) | active | 2024-06 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2369 | Necrotizing Fasciitis (SNOMED) | active | 2024-06 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2370 | Necrotizing Fasciitis (ICD10CM) | active | 2024-06 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2371 | Renal Impairment [Acute or Unspecified] (SNOMED) | active | 2024-06 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2372 | Renal Impairment [Acute or Unspecified] (ICD10CM) | active | 2024-06 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2373 | Coagulopathy [Unspecified Cause] (SNOMED) | active | 2024-06 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2374 | Coagulopathy [Unspecified Cause] (ICD10CM) | active | 2024-06 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2375 | Rash [Erythematous, Macular, or Desquamating of Unspecified Cause] (SNOMED) | active | 2024-06 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2376 | Rash [Erythematous, Macular, or Desquamating of Unspecified Cause] (ICD10CM) | active | 2024-06 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2377 | Soft Tissue Necrosis (SNOMED) | active | 2024-06 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2378 | Soft Tissue Necrosis (ICD10CM) | active | 2024-06 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2379 | Group A Streptococcus (Tests for Group A Strep in Specimen from Nonsterile Site by Culture and Identification Method) | active | 2024-06 | hl7 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2380 | Organisms (Tests in Specimen from Nonsterile Site by Culture and Identification) | active | 2024-06 | hl7 |
FHIR